05/31/2024
8:36 PM | Kruse Bo (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:54 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:42 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2024
4:04 PM | Y-mAbs Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
4:05 PM | Y-mAbs Therapeutics (Filer)
| Form ARS | |
04/29/2024
4:09 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
4:09 PM | Paradigm Biocapital Advisors LP (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC 13G | |
|
03/14/2024
4:01 PM | TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
8:17 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
5:17 AM | TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/07/2024
4:02 PM | Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:49 PM | Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
3:40 PM | Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:05 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
5:05 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
4:04 PM | Y-mAbs Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/06/2024
2:59 PM | ACORN BIOVENTURES, L.P. (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
4:54 PM | Lund-Hansen Torben (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
4:56 PM | Wilms Joris (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
4:58 PM | Lisby Steen (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
5:00 PM | Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
5:02 PM | Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
4:48 PM | Kruse Bo (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
4:52 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
5:45 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
3:15 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
6:40 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
3:40 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
7:27 AM | WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:26 AM | Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
4:25 PM | Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
4:25 PM | WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
4:14 PM | Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
4:15 PM | WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
4:14 PM | WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
4:15 PM | Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
3:47 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
4:15 PM | Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/08/2023
4:16 PM | Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
4:19 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
3:09 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The Only Energy Play You Should Be Looking At (Ad) Open AI’s Sam Altman recently helped this company raise $577 million in funding…
What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. |
10/18/2023
8:00 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2023
5:00 PM | TYAGI ASHU (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:00 PM | HEALY JAMES (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:01 PM | GILL DAVID N (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:02 PM | Ber Gerard (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:04 PM | Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:05 PM | Hamill Laura (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:30 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
